| Financial Year |
March 31 2023 |
| Monetary Funds |
349,176,322.09 |
| Held-for-trading Financial Assets |
353,821,514.80 |
| Notes Receivable |
1,198,000.00 |
| Accounts Receivable |
178,441,849.55 |
| Advances to Suppliers |
20,600,704.24 |
| Other Receivables |
6,898,221.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
608,286,817.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,772,191.30 |
| Total Current Assets |
1,549,195,621.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,714,302.10 |
| Investment Properties |
72,320,448.54 |
| Fixed Assetes |
250,405,005.85 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,521,883.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
28,390,779.88 |
| Deferred Income Tax Assets |
3,551,265.67 |
| Other Non-Current Assets |
497,309.09 |
| Sub-Total of Non-Current Assets |
402,320,567.04 |
| Total Assets |
1,951,516,188.58 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,876,603.00 |
| Accounts Payable |
82,223,628.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,960,194.48 |
| Taxes Payable |
3,489,713.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,082,237.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
11,071,370.07 |
| Sub-Total of Current Liabilities |
230,519,433.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
100,804.08 |
| Deferred Income Tax Liabilities |
2,184,068.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,784,153.13 |
| Total Liabilities |
242,303,587.05 |
| Paid-In Capital(Or Share Stock) |
457,848,260.00 |
| Capital Surplus |
524,906,518.99 |
| Surplus Reserve |
76,238,154.11 |
| LESS:Treasury Stock |
1,324,830.00 |
| Undistributed Profits |
651,544,498.43 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,709,212,601.53 |
| Owner's Equity（Stockholder's Equity） |
1,709,212,601.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,951,516,188.58 |
